Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Prognostic significance of SCC antigen in the serum of patients with head and neck cancerR Molina, M D Torres, M Moragas, et al.Actas Urologicas Espanolas|October 9, 2013
Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostatic specific antigenN Rodón, I Trías, M Verdú, et al.Nuclear Medicine Communications|August 19, 1999
Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activityF Pons, L Alvarez, P Peris, et al.Rheumatology (Oxford, England)|November 21, 2000
Collagen type Ialpha1 gene polymorphism in idiopathic osteoporosis in menP Peris, L Alvarez, J Oriola, et al.Prenatal Diagnosis|May 1, 1996
First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCGE Casals, A Fortuny, J G Grudzinskas, et al.Clinical Science (London, England : 1979)|September 21, 2000
S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured ratsR Deulofeu, A Parés, M Rubio, et al.Bone|September 24, 1999
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapyP Peris, L Alvarez, A Monegal, et al.Bone|November 13, 2001
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's diseaseL Alvarez, N Guañabens, P Peris, et al.Breast Cancer Research and Treatment|January 8, 1999
c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic valueR Molina, J Jo, X Filella, et al.Anticancer Research|September 2, 1999
C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patientsR Molina, J Jo, X Filella, et al.Pageof 10